Schizophrenia Research
Volume 76, Issue 1 , Pages 83-87 , 1 July 2005

Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia

  • Andrew O. Skinner

      Affiliations

    • Department of Psychiatry and Behavioral Science University of Louisville School of Medicine 3 East Mill Place Louisville, KY 40222, USA
    • ,
  • Sahebarao P. Mahadik

      Affiliations

    • Department of Psychiatry Medical College of Georgia, USA
    • ,
  • David L. Garver

      Affiliations

    • Department of Psychiatry and Behavioral Science University of Louisville School of Medicine 3 East Mill Place Louisville, KY 40222, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 502 727 5654.
    • Supported in part by VA Merit to Dr. Garver.

Received 8 June 2004 ,Revised 11 October 2004 ,Accepted 14 October 2004.

References 

  1. Arlt S, Beisiegel U, Kontush A. Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Current Opinion in Lipidology. 2002;13:289–294
  2. Arvindakahan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, et al. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry. 2003;53:56–64
  3. Bartzokis G, Nuechterlein KH, Lu PH, Gitlin M, Rogers S, Mintz J. Dysregulated brain development in adult men with schizophrenia: a magnetic resonance study. Biological Psychiatry. 2003;53:412–421
  4. Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. European Neuropsychopharmacology. 2003;12:145–152
  5. Bustillo JR, Lauriello J, Rowland LM, Thomson LM, Petropoulos H, Hammond R, et al. Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure. Schizophrenia Research. 2002;58:313–321
  6. Christensen J, Holcomb J, Garver DL. State-related changes in cerebral white matter may underlie psychosis exacerbation. Psychiatry Research. Neuroimaging. 2004;130:71–78
  7. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry. 2003;60:443–456
  8. Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naïve patients with schizophrenia. Biological Psychiatry. 2003;54:587–598
  9. Flynn SW, Lang DJ, Mackay AL, Goghari V, Vavasour IM, Whittall KP, et al. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post mortem analysis of oligodendrocyte proteins. Molecular Psychiatry. 2003;8:811–820
  10. Greco A, Minghetti L, Levi G. Isoprostanes, novel markers of oxidative injury, help understanding the pathogenesis of neurodegenerative diseases. Neurochemical Research. 2002;25:1357–1364
  11. Hunter MI, Nlemadim BD, Davidson DL. Lipid peroxidation products and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis patients. Neurochemical Research. 1985;10:1645–1652
  12. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology & Medicine. 1990;9:515–540
  13. Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research. 2002;58:1–10
  14. Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV. Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biological Psychiatry. 1990;28:535–539
  15. Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS. Elevated plasma lipid peroxidases at the onset of nonaffective psychosis. Biological Psychiatry. 1998;43:674–679
  16. Montine TJ, Neelt MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, et al. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology & Medicine. 2002;33:620–626
  17. Naidoo R, Knapp ML. Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clinical Chemistry. 1992;38:2449–2454
  18. Pall HS, Williams AC, Blake DR, Lunec J. Evidence of enhances lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet. 1987;2:596–599
  19. Simonian NA, Coyle JT. Oxidative stress in neurodegenerative diseases. Annual Review of Pharmacology and Toxicology. 1966;36:82–106

PII: S0920-9964(04)00385-8

doi: 10.1016/j.schres.2004.10.010

Schizophrenia Research
Volume 76, Issue 1 , Pages 83-87 , 1 July 2005

Article Tools

* Image Usage & Resolution